Provided by Tiger Trade Technology Pte. Ltd.

Renaissance Technologies Holdings

2,982.80
+17.680.60%
Number of Gainers:59
Number of Losers:35
Number of Flat:2
PE:- -
High:2,988.63
Open:2,964.29
Low:2,963.15
Close:2,965.12
Volume:754.12M
Turnover:146.52B
Market Cap:32.55T
Float Cap:30.58T

Loading ...

Rapid Revenue Surge in Data Observability Startups Driven by AI Agent Boom

Deep News
·
Aug 26

Oil, Nvidia Steady European Bourses Midday

MT Newswires Live
·
Aug 26

Jazz Pharmaceuticals Plans $1 Billion Exchangeable Senior Notes Due 2032

MT Newswires Live
·
Aug 26

US Companies Face Rise in Cyber Attacks

Reuters
·
Aug 26

Is AI-Driven Telerik, Kendo UI Overhaul And New CIO Altering The Investment Case For Progress (PRGS)?

Simply Wall St.
·
Aug 26

Nvidia, Oil Outlooks Limit Wall Street Pre-Bell; Asia, Europe Up

MT Newswires Live
·
Aug 26

LG CNS Teams with Naver Cloud to Build Liquid-Cooling Infrastructure at Samsung Data Center

Reuters
·
Aug 26

Allison Transmission CEO David S. Graziosi Disposes of Common Shares Worth $3.55 Million

Reuters
·
Aug 26

Cathie Wood Buys $17M in Cerebras Stock as AI Chip Race Intensifies, Sells AMD

TIPRANKS
·
Aug 26

Zoom Communications Price Target Maintained with a $130.00/Share by Needham

Dow Jones
·
Aug 26

LIVE Markets-Banks: Why This Bull Run May be Nearing Its End

Reuters
·
Aug 26

China’s YMTC Targets NAND Dominance by 2027: What It Means for Micron and SanDisk Stocks

TIPRANKS
·
Aug 26

Cable One COO Heather A. McCallion Files Initial Beneficial Ownership Statement (Form 3)

Reuters
·
Aug 26

New York Mayor Faces Off Against Amazon

Dow Jones
·
Aug 26

How To Earn $500 A Month From Salesforce Stock Ahead Of Q2 Earnings

Benzinga Earnings
·
Aug 26

Moderna : Deutsche Bank Raises Target Price to $125 from $45

THOMSON REUTERS
·
Aug 26

Jazz Pharmaceuticals Announces Private Offering of $1.0 Billion of Exchangeable Senior Notes Due 2032 and Concurrent Ordinary Share Repurchases

THOMSON REUTERS
·
Aug 26

Jazz Pharmaceuticals - Initial Purchasers May Buy up to $150 Mln Additional Notes

THOMSON REUTERS
·
Aug 26

Jazz Pharmaceuticals - Expects to Repurchase up to $225 Mln of Ordinary Shares Concurrently

THOMSON REUTERS
·
Aug 26

Jazz Pharmaceuticals - Net Proceeds from Offering Expected to be Used for General Corporate Purposes

THOMSON REUTERS
·
Aug 26